![Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fd63eb214ea90b377cbaa2b0d0bda2b9548b23ae/7-Figure3-1.png)
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
Cellular Intrinsic Mechanism Affecting the Outcome of AML Treated with Ara-C in a Syngeneic Mouse Model | PLOS ONE
![Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML](https://www.mdpi.com/cancers/cancers-13-00966/article_deploy/html/images/cancers-13-00966-g001.png)
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
![High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2001002082/2003731510/gr1.gif)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
![Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-018-0756-9/MediaObjects/13046_2018_756_Fig2_HTML.gif)
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG | Leukemia Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2013.297/MediaObjects/41375_2014_Article_BFleu2013297_Fig1_HTML.jpg)
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG | Leukemia
![Principles of Chemotherapy and Chemotherapy Complications Özlem Sönmez, MD Yeditepe University Hospital Section of Medical Oncology. - ppt download Principles of Chemotherapy and Chemotherapy Complications Özlem Sönmez, MD Yeditepe University Hospital Section of Medical Oncology. - ppt download](https://images.slideplayer.com/27/9222536/slides/slide_39.jpg)
Principles of Chemotherapy and Chemotherapy Complications Özlem Sönmez, MD Yeditepe University Hospital Section of Medical Oncology. - ppt download
![Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression](https://www.spandidos-publications.com/article_images/etm/14/2/etm-14-02-1081-g01.jpg)
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
![UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter](https://pbs.twimg.com/media/EEB3-InVUAAP0wU.jpg)
UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter
![Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6cdbc294-34aa-472d-8f49-bf7904daaf0f/gr1a.jpg)
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology
![X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/7a662cd6-4e37-40f6-9050-db057fcc2738/mol212146-fig-0006-m.jpg)